---
figid: PMC9266536__ijms-23-07426-g001
figtitle: 'Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Streptococcus suis 93A
pmcid: PMC9266536
filename: ijms-23-07426-g001.jpg
figlink: /pmc/articles/PMC9266536/figure/ijms-23-07426-f001/
number: F1
caption: Schematic diagram of fenretinide activity in cancer. Pointed arrows represent
  pathway activation, and blunt arrows represent pathway inhibition. Fenretinide activates
  PKCδ in the mitochondrial signalosome with consequent activation of PDK2, PDHC,
  TCA and increased ROS production. High increase of ROS activates the p38 apoptotic
  pathway with CytC release, caspase-9 activation and induction of apoptosis. Moderate
  increase of ROS activates the JNK autophagy pathway.Fenretinide induces translocation
  of RARβ-Nur77 dimer from the nucleus to the cytoplasm where Nur77 binds Bcl-2 allowing
  their conformational change towards pro-apoptotic structures. Fenretinide inhibition
  of DES1 increases DhCer/Cer ratio and triggers endoplasmic reticulum stress with
  blocking of the PI3K/AKT/mTOR and NF-KB signaling pathways, as well as with blocking
  of eIF2 phosphorylation due to PERK. Moreover, fenretinide inhibits mTORC2 and mTORC1
  by structural affinity with mTOR-ATP binding site.
papertitle: 'Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule.'
reftext: Rosa Luisa Potenza, et al. Int J Mol Sci. 2022 Jul;23(13):7426.
year: '2022'
doi: 10.3390/ijms23137426
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: fenretinide | anticancer drugs | nanomicellar formulations | repositioning
  | neuroinflammation | oxidative stress | neuroprotection | hormesis
automl_pathway: 0.9527197
figid_alias: PMC9266536__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC9266536__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9266536__ijms-23-07426-g001.html
  '@type': Dataset
  description: Schematic diagram of fenretinide activity in cancer. Pointed arrows
    represent pathway activation, and blunt arrows represent pathway inhibition. Fenretinide
    activates PKCδ in the mitochondrial signalosome with consequent activation of
    PDK2, PDHC, TCA and increased ROS production. High increase of ROS activates the
    p38 apoptotic pathway with CytC release, caspase-9 activation and induction of
    apoptosis. Moderate increase of ROS activates the JNK autophagy pathway.Fenretinide
    induces translocation of RARβ-Nur77 dimer from the nucleus to the cytoplasm where
    Nur77 binds Bcl-2 allowing their conformational change towards pro-apoptotic structures.
    Fenretinide inhibition of DES1 increases DhCer/Cer ratio and triggers endoplasmic
    reticulum stress with blocking of the PI3K/AKT/mTOR and NF-KB signaling pathways,
    as well as with blocking of eIF2 phosphorylation due to PERK. Moreover, fenretinide
    inhibits mTORC2 and mTORC1 by structural affinity with mTOR-ATP binding site.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pdk2
  - Mapk8
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Gnat2
  - Casp9
  - Rarb
  - Nr4a1
  - Bcl2
  - Pik3r1
  - Akt1
  - Nfkb1
  - Eif2ak3
  - Lamp1
  - Elf2
  - Efnb2
  - Eif2s2
  - PDK2
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - RARB
  - NR4A1
  - BCL2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - DESI2
  - DESI1
  - NFKB1
  - EIF2AK3
  - ELF2
  - EIF2S1
  - EIF2S3
  - EIF2S2
  - Pik3cg
---
